Pimecrolimus Cream
Product Images NDC 68682-110

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Pimecrolimus (NDC 68682-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oceanside Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemstructure.jpg (Chemstructure)

Chemical structure of the active ingredient Pimecrolimus, shown as a two-dimensional molecular diagram with atoms and bonds represented in a line-angle formula.*

FDA Label Image

Figure1.jpg (Figure1)

A line graph titled 'Body Surface Area Over Time' showing the percentage of body surface area affected over a span of 43 days. The graph compares two treatments: Pimecrolimus 1% and Vehicle. The Y-axis represents the percentage of body surface area affected, with error bars indicating the 95% confidence interval. The X-axis represents time in days. Pimecrolimus 1% shows a decrease in affected body surface area over time, while the Vehicle group remains relatively stable.*

FDA Label Image

Figure2.jpg (Figure2)

A line graph titled 'Mean Erythema Over Time' comparing mean erythema scores with 95% confidence intervals over a 43-day period for two treatments: Pimecrolimus 1% and Vehicle. The y-axis shows mean erythema scores from 0 to 6, and the x-axis shows time in days. The Pimecrolimus 1% group shows a decreasing erythema score over time, whereas the Vehicle group shows a stable score.*

FDA Label Image

Carton100g (Image 01)

Packaging label for Pimecrolimus Cream 1%, a topical cream containing 10 mg/g pimecrolimus. The label includes usage warnings for topical use only and cautions against ophthalmic use. Distributed by Oceanside Pharmaceuticals, manufactured by Bausch Health Companies Inc., product of Canada. Net weight is 100 g. The label also includes pharmacy instructions to provide the medication guide to patients.*

FDA Label Image

Carton60g (Image 02)

Packaging label for Pimecrolimus Cream 1%, a topical prescription cream labeled for topical use only and not for ophthalmic use. The labeled net weight is 60 g. The product is distributed by Oceanside Pharmaceuticals, a division of Bausch Health US, LLC, and manufactured by Bausch Health Companies Inc., Canada. Storage and ingredient information is included, along with cautions and instructions for use.*

FDA Label Image

Carton30g (Image 03)

Pimecrolimus Cream 1% topical cream packaging label by Oceanside Pharmaceuticals. The label states it is for topical use only and not for ophthalmic use, with a net weight of 30 grams. It includes instructions for rinsing eyes if the cream gets in them, storage conditions, and lists inactive ingredients. The label features the Oceanside Pharmaceuticals logo and a barcode, with manufacturer details indicating Bausch Health Companies Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.